Sterling Pharma Solutions is a global contract development and manufacturing organisation (CDMO) and is the largest independent UK provider of small molecule API development and manufacturing services to the pharmaceutical industry, specialising in handling challenging chemistries. With over 50 years’ experience, the team can manage the most complex API and API intermediate challenges from proof-of-concept to commercial manufacture.

Sterling has four facilities; its HQ in Dudley, Northumberland, UK, two sites in the US, the first in Cary, North Carolina and the second in Germantown, Wisconsin, and now a bioconjugation and ADCs facility in Deeside, North Wales, UK.

For more information visit www.sterlingpharmasolutions.com.

Authors

John Mykytiuk

John Mykytiuk obtained his degree in chemistry and PhD in polymerisation reaction kinetics from the University of Bradford. Following two post-doctoral positions at Sussex University, he joined Cyana...

Emma Rhodes

Emma Rhodes, Head of Research and Development at Sterling.

...

❮ ❯

Articles Interviews

17843

Solid-form development: the key to API success?...

26445

Emma Rhodes, Head of Research and Development at S...